The Claim

The compounds candesartan cilexetil at 30 ppm, geranylgeranylacetone at 600 ppm, and MIF098 at 240 ppm did not demonstrate significant lifespan extension in male or female UM-HET3 mice under the tested conditions.

Source: 17‐a‐estradiol late in life extends lifespan in aging UM‐HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
13score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

Description
1 study reviewed
In plain English

Scientists tested three different compounds at specific doses in mice to see if they could help the mice live longer, but none of them made a meaningful difference in how long the mice lived.

See the scientific wording

Candesartan cilexetil (30 ppm), geranylgeranylacetone (600 ppm), and MIF098 (240 ppm) were not associated with significant lifespan extension in either male or female UM-HET3 mice at the doses tested

What the research says

1 study

  1. Study: 17‐a‐estradiol late in life extends lifespan in aging UM‐HET3 male mice; nicotinamide riboside and three other drugs do not affect lifespan in either sex

    The study tested exactly the three drugs mentioned in the claim at the same doses in the same type of mice, and found that none of them extended lifespan - exactly what the claim says.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.